Solana Co-Founder Raj Gokal's Emotional Reaction to CRISPR Diabetes Cure: 'The Future Is So Bright'
Raj Gokal, Solana President, shares his 7-year biotech journey fighting diabetes as a world-first CRISPR trial lets a patient produce insulin naturally—no more daily shots. A techno-optimist milestone!